Tetsuo Tani

发表

A Case of Disseminated Cryptococcal Infection and Concurrent Lung Tuberculosis in a Patient under Steroid Therapy for Interstitial Pneumonia

T. Betsuyaku, Y. Okada, Yusuke Suzuki, 2015, Case reports in pulmonology.

Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report.

T. Betsuyaku, K. Soejima, M. Ishii, 2016, Molecular and clinical oncology.

Remarkable Differences in Calcification between the Primary Tumor and Metastatic Lymph Nodes in a Patient with ALK-Positive Non-Small-Cell Lung Cancer

Hidefumi Koh, Y. Funatsu, H. Irie, 2022, Case reports in pulmonology.

CMAR_A_330103 7497..7503

K. Fukunaga, K. Soejima, Hidefumi Koh, 2021 .

Abstract 4: ABT-263 is effective in a subset of non-small cell lung cancer cell lines

T. Betsuyaku, K. Soejima, K. Naoki, 2015 .

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.

C. Paweletz, P. Jänne, J. Köhler, 2022, Cancer cell.

Case Report Remarkable Differences in Calcification between the Primary Tumor and Metastatic Lymph Nodes in a Patient with ALK-Positive Non-Small-Cell Lung Cancer

Hidefumi Koh, Y. Funatsu, H. Irie, 2022 .

Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer

T. Betsuyaku, T. Kohno, H. Asamura, 2021, Cancer Research.

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.

C. Paweletz, P. Hammerman, P. Lizotte, 2020, The Journal of clinical investigation.

Multiple roles of extracellular fibroblast growth factors in lung cancer cells.

T. Betsuyaku, K. Soejima, K. Naoki, 2015, International journal of oncology.

KRAS G12C inhibition and innate immune targeting

D. Barbie, S. Kitajima, E. Knelson, 2021, Expert opinion on therapeutic targets.

Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab

K. Soejima, K. Naoki, H. Terai, 2019, Molecular Cancer Therapeutics.

Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations.

K. Soejima, K. Naoki, H. Terai, 2019, Lung cancer.

In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer

T. Betsuyaku, S. Kobayashi, D. Costa, 2015, Oncotarget.

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

T. Betsuyaku, K. Soejima, K. Naoki, 2014, Lung cancer.

The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells

D. Barbie, N. Ahsan, N. Tapinos, 2022, bioRxiv.

Engineering the Immune Adaptor Protein STING as a Biologic

D. Barbie, S. Kitajima, Jiahe Li, 2021, bioRxiv.

Tumor-Derived cGAMP Regulates Activation of the Vasculature

C. Paweletz, R. Kamm, V. Chiono, 2020, Frontiers in Immunology.

Activation of tumor-cell STING primes NK-cell therapy.

C. Paweletz, M. Tolstorukov, W. Richards, 2022, Cancer immunology research.

Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer

T. Betsuyaku, K. Soejima, K. Naoki, 2016, Molecular Cancer Research.

Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).

T. Betsuyaku, Makoto Nishino, T. Terashima, 2017, Molecular and clinical oncology.

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

K. Soejima, K. Naoki, H. Terai, 2019, Cancer Chemotherapy and Pharmacology.

Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK-Translocated Lung Cancer Cells

T. Betsuyaku, K. Soejima, K. Naoki, 2015, Molecular Cancer Therapeutics.

Angiosarcoma Identified by Diffuse Alveolar Hemorrhaging Associated with Disseminated Intravascular Coagulation

Yoshihisa Suzuki, Hidefumi Koh, Tomohiko Tanigawa, 2019 .

First case report of thyroid abscess caused by Helicobacter cinaedi presenting with thyroid storm

Hidefumi Koh, Ken Yajima, Y. Otsuka, 2019, BMC Infectious Diseases.

Outcome of patients with lung cancer and severe psychiatric disorder admitted to a medical psychiatric unit.

Tatsuya Yamamoto, Hidefumi Koh, A. Iwamaru, 2020, Molecular and clinical oncology.

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

C. Paweletz, P. Janne, P. Lizotte, 2022, Cancer research.

Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer

K. Fukunaga, K. Soejima, Hidefumi Koh, 2021, Cancer management and research.

A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer

T. Betsuyaku, Makoto Nishino, K. Soejima, 2015, Cancer Chemotherapy and Pharmacology.

Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells

K. Fukunaga, K. Soejima, K. Naoki, 2020, Cancer science.

Engineering the Immune Adaptor Protein STING as a Functional Carrier

D. Barbie, S. Kitajima, Jiahe Li, 2021 .

Factors associated with improvements in subjective symptoms of obstructive sleep apnea syndrome after continuous positive airway pressure therapy

T. Betsuyaku, K. Fukunaga, R. Shirahama, 2019, Sleep and Breathing.